Qian Liu

Jinmin Zhao, Jiake Xu, Rohan A. Davis, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Isoliensinine Suppresses Osteoclast Formation Through NF-κB Signaling Pathways and Relieves Ovariectomy-Induced Bone Loss

Xinli Zhan, Jiake Xu, Yun Liu, 2022, Frontiers in Pharmacology.

Aminooxyacetic acid hemihydrochloride inhibits osteoclast differentiation and bone resorption by attenuating oxidative phosphorylation

Biao-Bing Yang, KE Rong, A. Qin, 2022, Frontiers in Pharmacology.

Chrysin Protects Against Titanium Particle-Induced Osteolysis by Attenuating Osteoclast Formation and Function by Inhibiting NF-κB and MAPK Signaling

Jinmin Zhao, Jiake Xu, Li Li, 2022, Frontiers in Pharmacology.

Lonafarnib Inhibits Farnesyltransferase via Suppressing ERK Signaling Pathway to Prevent Osteoclastogenesis in Titanium Particle-Induced Osteolysis

Shiyao Gao, Jinmin Zhao, Jiake Xu, 2022, Frontiers in Pharmacology.

Inhibitory effects of biochanin A on titanium particle‐induced osteoclast activation and inflammatory bone resorption via NF‐κB and MAPK pathways

Xixi Lin, Jinmin Zhao, Jiake Xu, 2020, Journal of cellular physiology.

Betulinic Acid Protects From Bone Loss in Ovariectomized Mice and Suppresses RANKL-Associated Osteoclastogenesis by Inhibiting the MAPK and NFATc1 Pathways

Jinmin Zhao, Jiake Xu, Liwei Wu, 2020, Frontiers in Pharmacology.

Ellagic acid protects ovariectomy‐induced bone loss in mice by inhibiting osteoclast differentiation and bone resorption

Xixi Lin, Jinmin Zhao, Jiake Xu, 2020, Journal of cellular physiology.

Cytochalasin Z11 inhibits RANKL-induced osteoclastogenesis via suppressing NFATc1 activation

Jinmin Zhao, Jiake Xu, R. Tan, 2019, RSC advances.

Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species

Jinmin Zhao, Jiake Xu, S. Fan, 2019, Theranostics.

Cumambrin A prevents OVX‐induced osteoporosis via the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathways

Qiong Gu, Jun Xu, Jinmin Zhao, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Diosmetin inhibits osteoclast formation and differentiation and prevents LPS‐induced osteolysis in mice

Xixi Lin, Jinmin Zhao, Jiake Xu, 2018, Journal of cellular physiology.

Deguelin inhibits RANKL‐induced osteoclastogenesis in vitro and prevents inflammation‐mediated bone loss in vivo

Weiqi Han, Wanlei Yang, Xuanyuan Lu, 2018, Journal of cellular physiology.

Dual effects of baicalin on osteoclast differentiation and bone resorption

A. Qin, Weiqi Han, Wei He, 2018, Journal of cellular and molecular medicine.

Artesunate inhibits RANKL‐induced osteoclastogenesis and bone resorption in vitro and prevents LPS‐induced bone loss in vivo

Shaohui Zong, Xixi Lin, Jinmin Zhao, 2018, Journal of cellular physiology.

Nitidine chloride prevents OVX-induced bone loss via suppressing NFATc1-mediated osteoclast differentiation

A. Qin, Xixi Lin, Jiake Xu, 2016, Scientific Reports.

Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways

Mingli Yang, Jun Xu, Jinmin Zhao, 2015, International journal of molecular sciences.

Alpinetin Ameliorates Bone Loss in LPS-induced Inflammation Osteolysis via ROS Mediated P38/PI3K signaling pathway.

Jiake Xu, Hui Wang, Yuangang Su, 2022, Pharmacological research.

Scutellarein inhibits RANKL‐induced osteoclast formation in vitro and prevents LPS‐induced bone loss in vivo

Xixi Lin, Jinmin Zhao, Jiake Xu, 2018, Journal of cellular physiology.

AKT/GSK3β/NFATc1 and ROS signal axes are involved in AZD1390-mediated inhibitory effects on osteoclast and OVX-induced osteoporosis.

Jiake Xu, Yuangang Su, Qian Liu, 2022, International immunopharmacology.

Osteoblast-derived EGFL6 couples angiogenesis to osteogenesis during bone repair

A. Qin, N. Pavlos, Jinmin Zhao, 2021, Theranostics.

Retraction of: A005, a novel inhibitor of phosphatidylinositol 3-kinase/mammalian target of rapamycin, prevents osteosarcoma-induced osteolysis.

A. Qin, Xixi Lin, Jiake Xu, 2019, Carcinogenesis.

Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways

Xixi Lin, Jinmin Zhao, Zuoxing Wu, 2021, Drug design, development and therapy.

Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption.

Xixi Lin, Jinmin Zhao, Jiake Xu, 2020, Life sciences.

Cyanidin Chloride inhibits ovariectomy‐induced osteoporosis by suppressing RANKL‐mediated osteoclastogenesis and associated signaling pathways

Xixi Lin, Mei Liu, N. Pavlos, 2018, Journal of cellular physiology.

Corilagin attenuates osteoclastic osteolysis by enhancing HO‐1 and inhibiting ROS

Yuangang Su, Jiamin Liang, Qian Liu, 2022, Journal of biochemical and molecular toxicology.

Anti-Osteoclast Effect of Exportin-1 Inhibitor Eltanexor on Osteoporosis Depends on Nuclear Accumulation of IκBα–NF-κB p65 Complex

Lili Tang, Jiake Xu, Jun-chun Chen, 2022, Frontiers in Pharmacology.

Dihydroartemisinin, an Anti‐Malaria Drug, Suppresses Estrogen Deficiency‐Induced Osteoporosis, Osteoclast Formation, and RANKL‐Induced Signaling Pathways

Mingli Yang, Xixi Lin, Jinmin Zhao, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Andrographolide Inhibits Ovariectomy-Induced Bone Loss via the Suppression of RANKL Signaling Pathways

Xixi Lin, Jinmin Zhao, Jiake Xu, 2015, International journal of molecular sciences.

Eriodictyol Inhibits RANKL‐Induced Osteoclast Formation and Function Via Inhibition of NFATc1 Activity

Mingli Yang, Jun Xu, Jinmin Zhao, 2016, Journal of cellular physiology.

Chitosan derived nitrogen-doped carbon dots suppress osteoclastic osteolysis via downregulating ROS.

Guanxiong Liu, Wenxin He, Xiankun Cao, 2020, Nanoscale.

Epoxymicheliolide inhibits osteoclastogenesis and resists OVX-induced osteoporosis by suppressing ERK1/2 and NFATc1 signaling.

Jinmin Zhao, Jiake Xu, F. Long, 2022, International immunopharmacology.

Cepharanthine suppresses osteoclast formation by modulating the nuclear factor‐κB and nuclear factor of activated T‐cell signaling pathways

Xixi Lin, Jinmin Zhao, Jiake Xu, 2018, Journal of cellular biochemistry.

Pharmacology-based molecular docking of 4-methylcatechol and its role in RANKL-mediated ROS/Keap1/Nrf2 signalling axis and osteoclastogenesis.

Jiake Xu, Liwei Wu, Jing Li, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Corylifol A protects against ovariectomized-induced bone loss and attenuates RANKL-induced osteoclastogenesis via ROS reduction, ERK inhibition, and NFATc1 activation.

Xixi Lin, Yuangang Su, Jiamin Liang, 2023, Free radical biology & medicine.

Isosinensetin alleviates estrogen deficiency-induced osteoporosis via suppressing ROS-mediated NF-κB/MAPK signaling pathways.

Jiake Xu, Yuangang Su, Qian Liu, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Oroxylin A reduces osteoclast formation and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation.

Jinmin Zhao, Jiake Xu, X. Feng, 2021, Biochemical pharmacology.

A missense mutation sheds light on a novel structure–function relationship of RANKL

N. Pavlos, Jinmin Zhao, Jiake Xu, 2020, Journal of cellular physiology.

Onc201 reduces osteoclastogenesis and prevents ovariectomy-induced bone loss via inhibiting RANKL-induced NFATc1 activation and the integrin signaling pathway.

Jiake Xu, Liwei Wu, Jing Li, 2022, European journal of pharmacology.

Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL‐induced activation of NF‐κB and ERK

Jiake Xu, E. Ang, Xiaohong Yang, 2011, Journal of cellular biochemistry.

Phosphatidyl inositol 3-kinase (PI3K)-mTOR inhibitor PKI-402 inhibits breast cancer induced osteolysis.

Xixi Lin, G. Yao, Fangming Song, 2019, Cancer letters.

Tiliroside is a new potential therapeutic drug for osteoporosis in mice

Xixi Lin, Jinmin Zhao, Jiake Xu, 2019, Journal of cellular physiology.

Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways

Jinmin Zhao, Jiake Xu, Zuoxing Wu, 2021, Frontiers in Pharmacology.

Pectolinarigenin prevents bone loss in ovariectomized mice and inhibits RANKL‐induced osteoclastogenesis via blocking activation of MAPK and NFATc1 signaling

Jinmin Zhao, Jiake Xu, Yu Xiao, 2019, Journal of cellular physiology.

Vx-11e protects against titanium-particle-induced osteolysis and osteoclastogenesis by supressing ERK activity.

A. Qin, Xixi Lin, Jinmin Zhao, 2019, Biochemical and biophysical research communications.

Monocrotaline Suppresses RANKL-Induced Osteoclastogenesis In Vitro and Prevents LPS-Induced Bone Loss In Vivo

Shaohui Zong, Jinmin Zhao, Jiake Xu, 2018, Cellular Physiology and Biochemistry.

Injectable calcium phosphate ceramics prevent osteoclastic differentiation and osteoporotic bone loss: Potential applications for regional osteolysis.

Jinmin Zhao, Tongmeng Jiang, Li Zheng, 2020, Materials science & engineering. C, Materials for biological applications.

Sclareol prevents ovariectomy-induced bone loss in vivo and inhibits osteoclastogenesis in vitro via suppressing NF-κB and MAPK/ERK signaling pathways.

Zengjie Zhang, Jiake Xu, Xiangyang Wang, 2019, Food & function.

Fangchinoline protects against bone loss in OVX mice via inhibiting osteoclast formation, bone resorption and RANKL-induced signaling

Jinmin Zhao, Jiake Xu, Lin Zhou, 2020, International journal of biological sciences.

Vaccarin prevents titanium particle‐induced osteolysis and inhibits RANKL‐induced osteoclastogenesis by blocking NF‐κB and MAPK signaling pathways

Xinli Zhan, Xixi Lin, Jinmin Zhao, 2019, Journal of cellular physiology.

Carnosol suppresses RANKL‐induced osteoclastogenesis and attenuates titanium particles‐induced osteolysis

Liangliang Xu, Jiake Xu, Junxiong Qiu, 2020, Journal of cellular physiology.

Ethyl caffeate inhibits macrophage polarization via SIRT1/NF-κB to attenuate traumatic heterotopic ossification in mice.

Hui Wang, Yuangang Su, Jiamin Liang, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Obacunone targets macrophage migration inhibitory factor (MIF) to impede osteoclastogenesis and alleviate ovariectomy-induced bone loss

Sitao Hu, Jiake Xu, Lin Zheng, 2023, Journal of advanced research.

Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice

Xixi Lin, Jinmin Zhao, Jiake Xu, 2020, Frontiers in Pharmacology.

Evodiamine inhibits RANKL‐induced osteoclastogenesis and prevents ovariectomy‐induced bone loss in mice

Jiake Xu, Jennifer Tickner, Xiangyang Wang, 2018, Journal of cellular and molecular medicine.

Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis.

Jinmin Zhao, Jiake Xu, Ge Zhang, 2017, Current drug targets.

Madecassoside inhibits estrogen deficiency‐induced osteoporosis by suppressing RANKL‐induced osteoclastogenesis

Huazi Xu, Jiake Xu, Jennifer Tickner, 2018, Journal of cellular and molecular medicine.

Pteryxin suppresses osteoclastogenesis and prevents bone loss via inhibiting the MAPK/Ca2+ signaling pathways mediated by ROS.

Jiake Xu, Jing Li, Qian Liu, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Advances in SEMA3F regulation of clinically high-incidence cancers.

Qian Liu, Dezhi Song, Qian Huang, 2023, Cancer biomarkers : section A of Disease markers.

CGK733 alleviates ovariectomy-induced bone loss through blocking RANKL-mediated Ca2+ oscillations and NF-κB/MAPK signaling pathways

Jiake Xu, Yuangang Su, Qian Liu, 2023, iScience.

Parthenolide inhibits pro-inflammatory cytokine production and exhibits protective effects on progression of collagen-induced arthritis in a rat model

N. Sims, R. Tan, Z. Lin, 2015, Scandinavian journal of rheumatology.

Eriodictyol Inhibits RANKL‐Induced Osteoclast Formation and Function Via Inhibition of NFATc1 Activity

Mingli Yang, Jinmin Zhao, Jiake Xu, 2016, Journal of cellular physiology.

Tussilagone inhibits osteoclastogenesis by modulating mitochondrial function and ROS production involved Nrf2 activation.

Fangming Song, Yuangang Su, Qian Liu, 2023, Biochemical pharmacology.

Cichoric acid targets RANKL to inhibit osteoclastogenesis and prevent ovariectomy-induced bone loss.

Fangming Song, Yuangang Su, Qian Liu, 2024, Phytotherapy research : PTR.

Ursolic acid alleviates steroid-induced avascular necrosis of the femoral head in mouse by inhibiting apoptosis and rescuing osteogenic differentiation.

Yuyang Wu, Qian Liu, Qian Liu, 2023, Toxicology and applied pharmacology.

Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways

Yuangang Su, Qian Liu, Jinmin Zhao, 2024, Cell death discovery.

Antioxidant enzyme Prdx1 inhibits osteoclastogenesis via suppressing ROS and NFATc1 signaling pathways.

Fangming Song, Qian Liu, Chao Wang, 2024, Journal of cellular physiology.